Thrombocytopenia associated with etretinate therapy

Acta Haematol. 1988;79(2):112-3. doi: 10.1159/000205733.

Abstract

A case of thrombocytopenia following etretinate therapy for psoriasis is presented. Etretinate appeared to be the cause of thrombocytopenia. Patients on etretinate are recommended to have their platelet count monitored.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Etretinate / adverse effects*
  • Etretinate / therapeutic use
  • Female
  • Humans
  • Psoriasis / drug therapy
  • Thrombocytopenia / chemically induced*

Substances

  • Etretinate